Standout Papers

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases 2019 2026 2021 2023 1.3k
  1. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (2019)
    Kevin R. Flaherty, Athol U. Wells et al. New England Journal of Medicine

Citation Impact

Citing Papers

Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
A comparison of deep learning performance against health-care professionals in detecting diseases from medical imaging: a systematic review and meta-analysis
2019 Standout
Diagnostic accuracy of deep learning in medical imaging: a systematic review and meta-analysis
2021 Standout
Systemic sclerosis-associated interstitial lung disease
2020
Deep learning for classifying fibrotic lung disease on high-resolution computed tomography: a case-cohort study
2018

Works of Anand Devaraj being referenced

Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
2017
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Rankless by CCL
2026